L
Lanjuan Li
Researcher at Zhejiang University
Publications - 5
Citations - 24309
Lanjuan Li is an academic researcher from Zhejiang University. The author has contributed to research in topics: Randomized controlled trial & Clinical trial. The author has an hindex of 4, co-authored 5 publications receiving 18269 citations. Previous affiliations of Lanjuan Li include Guangzhou Medical University.
Papers
More filters
Journal ArticleDOI
Clinical Characteristics of Coronavirus Disease 2019 in China.
Wei-jie Guan,Zhengyi Ni,Yu Hu,Wenhua Liang,Chun-Quan Ou,Jianxing He,Lei Liu,Hong Shan,Chunliang Lei,David S.C. Hui,Bin Du,Lanjuan Li,Guang Zeng,Kowk-Yung Yuen,Ruchong Chen,Chun-Li Tang,Tao Wang,Ping-Yan Chen,Jie Xiang,Shiyue Li,Jinlin Wang,Zi-jing Liang,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Nanshan Zhong +36 more
TL;DR: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness, and patients often presented without fever, and many did not have abnormal radiologic findings.
Posted ContentDOI
Clinical characteristics of 2019 novel coronavirus infection in China
Wei-jie Guan,Zhengyi Ni,Yu Hu,Wenhua Liang,Chun-Quan Ou,Jianxing He,Lei Liu,Hong Shan,Chunliang Lei,David S.C. Hui,Bin Du,Lanjuan Li,Guang Zeng,Kowk-Yung Yuen,Ruchong Chen,Chun-Li Tang,Tao Wang,Ping-Yan Chen,Jie Xiang,Shiyue Li,Jinlin Wang,Zi-jing Liang,Yi-xiang Peng,Li Wei,Yong Liu,Ya-hua Hu,Peng Peng,Jian-ming Wang,Ji-yang Liu,Zhong Chen,Gang Li,Zhi-jian Zheng,Shao-qin Qiu,Jie Luo,Chang-jiang Ye,Shao-yong Zhu,Nanshan Zhong +36 more
TL;DR: The 2019-nCoV epidemic spreads rapidly by human-to-human transmission and the disease severity (including oxygen saturation, respiratory rate, blood leukocyte/lymphocyte count and chest X-ray/CT manifestations) predict poor clinical outcomes.
Journal ArticleDOI
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trial.
Ke Hu,Wei-jie Guan,Ying Bi,Wei Zhang,Lanjuan Li,Boli Zhang,Qingquan Liu,Yuanlin Song,Xingwang Li,Zhongping Duan,Qingshan Zheng,Zifeng Yang,Jingyi Liang,Mingfeng Han,Lianguo Ruan,Chaomin Wu,Yunting Zhang,Zhen-Hua Jia,Nanshan Zhong +18 more
TL;DR: Lianhuaqingwen (LH) capsule, a repurposed marketed Chinese herb product, has been proven effective for influenza and could be considered to ameliorate clinical symptoms of Covid-19.
Journal ArticleDOI
Efficacy and safety of Ban-Lan-Gen granules in the treatment of seasonal influenza: study protocol for a randomized controlled trial.
Li Zhengtu,Lanjuan Li,Tingting Chen,Li Chuyuan,Wang Deqin,Zifeng Yang,Zifeng Yang,Nanshan Zhong,Nanshan Zhong +8 more
TL;DR: The first clinical trial for treatment using a single herb against influenza A and B viruses in China is described, and this clinical trial will serve as an example for the study of other traditional herbal medicines in evidence-based clinical trials.
Posted ContentDOI
Developing an Individualized Clinical Prediction Rules of Antihypertensive Drugs: A Study Protocol Based on Real-world Practice
TL;DR: This study is aimed to provide a pragmatic method to support clinical decisions for patients who has received antihypertensive drugs before long-term diagnosis of hypertension in real world practice according to their characteristics that are accessible to clinicians.